In this communication we explore the regulation of hapten-specific killing to both the trinitrophenol (TNP)-and azobenzenearsonate (ABA)-coupled cells. We present evidence indicating that Lyt-1 + T cells are required for the generation of haptenspecific CTL. This helper T cell requirement can be replaced by some factor(s) present in the supernatant of rat spleen cells stimulated with Con A (Con A-Sup). In addition, the generation of hapten-specific killing is susceptible to tolerization. At least two distinct mechanisms of unresponsiveness appear to be operative. Regulation by antigen-specific Tsl cells appears to function at the level of helper T cell. Furthermore, a second nontransferable state of unresponsiveness is found. The significance of these findings will be discussed in terms of cellular regulation of generation of CTL in mice.
assay. The assays were performed in duplicate. All cultures were assayed on both modified and unmodified targets, and the background lysis on unmodified targets was substrated. All the experiments have been done at least three times, with comparable results.
Rat Con A Supernatant. The preparation of Con A-stimulated rat spleen cell culture supernatant has been described in detail (4) . Supernatants used in this study were all from one lot, which gives 50% maximum cpm of the IL-2-dependent L2.2 cell line (4) at a dilution of 1:50. Control supernatants consist only of alpha-methyl manoside in identical media. All dilutions shown are final concentrations added at the beginning of culture.
Serum Treatment. Monoclonal anti-Ly-l.2 antibodies were used at 1:200 and were kindly provided by Dr. F. W. Shen (Memorial Sloan-Kettering Cancer Institute, New York). 5 × 10 v spleen cells were incubated for 45 min at room temperature with 1 ml of diluted anti-Ly-l.2 antibody, washed twice, and then incubated with 1 ml of 1:7 dilution of Low Tox rabbit complement (Accurate Chemical and Scientific Corp., Westbury, NY) for 30 min at 37° (2. Results and Discussion In our previous report, we found that in vivo priming followed by in vitro restimulation was required for generation of hapten-specific CTL and that adoptive transfer of suppressor T cells (Ts) induced by intravenous injection of haptenconjugated spleen cells (TNP-SC) can limit the in vivo priming of cytotoxic T cells (3) . This requirement for in vivo priming has been suggested to be at least in part necessary for the activation of a helper T cell subpopulation, which provides a differentiation signal for the activation of cytotoxic T cells (1, 5) .
To further investigate the role of helper T cells in the generation of ABA-specific cytotoxic T cells in vitro, we examined the effect of treating the responder cells with a monoclonal anti Ly-l.2 + antibody plus complement to eliminate Ly-l.2+-bearing helper T cells. As shown in Table I , treatment of responder cells with anti Ly~l.2 + antibodies plus complement completely abrogated their ability to generate CTL.
To further clarify whether the elimination of ABA-specific CTL response by antiLy-l.2 + plus complement treatment is due to the removal of helper T cells or elimination of Ly-l,2,3 ÷ cytotoxic T cell precursors (6), we investigated the effect of adding Con A-Sup in vitro. Our results shown in Table I clearly demonstrated that in vitro addition of Con A-Sup can restore the response of aLy-1.2 + plus complementtreated responder cells. Thus, the CTL is not appreciably altered by the aLy-l,2 + treatment, but requires a Ly-l.2 + cell that can be replaced by factors present in Con A-Sup. The mechanisms and the molecules in the Con A-Sup that are responsible for providing the necessary signals for the induction of CTL have not been addressed in our experiment. The molecule responsible for the helper activity might be IL-2, which is present in the Con A-Sup (7), as purified IL-2 has been reported able to provide nonspecific helper signals required for the activation of CTL (8) . Based on the above experiments, we investigated the mode of action of hapten-specific Ts. Because two cellular components are required for the generation of effector CTL, Ts might work either by inhibiting the helper T cell or by limiting the CTL. In addition, because we were unable to demonstrate any Ts activity in in vitro mixing experiments (unpublished results), we postulated that Ts are functioning only during in vivo priming. If the Ts works primarily at the level of helper T cells, we would expect CTL precursors to be present in a suppressed animal. To address this issue, an exogenous source of helper signals was added to the in vitro restimulation of a suppressed culture.
The result of such an experiment is shown in Table II . TNP-specific Ts induced in BALB/c mice when transferred into naive recipients will significantly inhibit the in vivo priming of TNP-specific CTL (compare group B to group A). Furthermore, addition of Con A-Sup as an exogenous source of helper signals in vitro, but not control supernatants, completely abrogated the Ts effect (groups C, D, and E). This CTL activity in the presence of Con A-Sup is hapten specific (data not shown). Identical experiments were performed using another hapten in A/J mice, and the results are presented in the lower one-half of Table II . ABA-specific Tsl, when transferred into naive recipients, inhibits the in vivo priming of ABA-specific CTL. Similar to the observation in the TNP system, suppression in the ABA system can also be reversed by in vitro addition of Con A-Sup. These results, in some respects, mimic the aLy-l.2 + plus complement experiment (Table I ) and thus allow us to suggest that Ts might inhibit the generation of CTL by inhibiting the helper T cells.
Our results are consistent with the hypothesis that the Con A-Sup reversed suppression by providing a helper signal in the same way that it provides the necessary signal in the aLy-l.2+-depleted cultures. This observation is in some respects similar to the earlier findings of Butler et al. (9) . The mechanisms whereby Ts regulates helper T Table III . Thus, we identified two unresponsive states in a hapten-specific CTL system that differ in their ability to be reconstituted by Con A-Sup. The exact mechanisms that determine why the unresponsiveness, cannot be overcome in tolerized mice in contrast to suppressed mice, by in vitro addition of Con A-Sup, are not clear. One trivial explanation is that there are simply more Ts in a nontransfer situation. Thus, more Con A-Sup might be required for reversal of unresponsiveness to occur. However, this appears unlikely because even when we added a three times higher concentration of Con A-stimulated culture supernatant, no significant increase in CTL activity was observed. Another possibility is that there are additional subpopulations of Ts in the tolerized animals that work directly on CTL or their precursors and, thus, result in a nonreversible defect. In addition, it is possible that intravenous injection of hapten-conjugated spleen cells not only induces Ts, but also results in a direct blockade of CTL precursors. A dual mechanism of immunological unresponsiveness involving both Ts and receptor blockade has been shown to exist in the regulation of contact sensitivity to DNFB in mice (14) .
TABLE III
It is not known why unresponsiveness induced by water-soluble TNBS can be reversed by Con A-Sup (9), whereas unresponsiveness induced by TNP-SC failed to do so. However, it has been shown (14) in the regulation of the contact sensitivity system that intravenous injection of DNBS and DNP-SC represents two very different tolerogenie regimens. In addition, reports from other laboratories (15) (16) (17) were unable to induce immunologic tolerance in vivo using TNP-SC, but the experimental protocol these investigators used is quite different from ours. In our experimental design, after intravenous tolerization, there is an additional in vivo priming before in vitro restimulation.
The inability of Con A-Sup to reverse unresponsiveness has certain implications concerning the mechanism of activation of CTL. It has been proposed recently (5) that two helper T cells might be required for the activation of CTL. Unprimed CTL precursors in vivo might require a differentiation signal from one helper T cell and a proliferation signal (probably mediated by IL-2) from a second set of helper T cells in the presence of antigen to generate CTL. In the absence of the first signal, unprimed CTL precursors were unable to accept the IL-2 signal. Therefore, it is possible that intravenous injection of hapten-conjugated spleen cells might have inactivated the first helper T cell that is required for the delivery of the first signal and, thus, resulted in the failure to generate any CTL even in the presence of exogenous helper signals. On the other hand, suppressor T cells, when adoptively transferred to a recipient, might allow the activation of the first helper T cells but inhibit the activity of second set of helper T cells. Experiments are now in progress to address these issues.
Summary
Treatment of responder cells with monoclonal anti-Ly-1,2 antibodies plus complement in vitro completely eliminated their ability to generate azobenzenearsonate (ABA)-specific cytolytic T lymphocytes (CTL). However, addition of the concanavalin A-stimulated supernatants of rat spleen cells (Con A-Sup) can fully reconstitute the response. Therefore, Lyt-1,2-bearing T cells are required for the generation of ABAspecific CTL, and such requirement can be replaced by factors present in the Con ASup. Suppressor T cells (Ts), when adoptively transferred into naive recipients, will inhibit the in vivo priming of CTL. This inhibition can also be reversed by in vitro addition of Con A-Sup. Furthermore, mice serving as donors of Ts also show profound unresponsiveness when primed and restimulated in vitro. In contrast to the Tsmediated inhibition, in vitro addition of Con A-Sup was unable to abolish the unresponsiveness observed in these cultures. Thus, we identified two unresponsive states in a hapten-specific killing system that differ in their ability to be reconstituted by Con A-Sup.
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